N
CO

Natixis’s Global Cord Blood Corporation CO Stock Holding History

Natixis’s Portfolio CO Stock Details CO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-16,800
Closed -$67K – 619
2013
Q4 		$67K Buy
+16,800
New +$66.9K ﹤0.01% 520

Other funds holding CO

CCM
Cortex Capital Management Fort Worth, Texas $86.4M AUM 1.54% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MCM
McKinley Capital Management Anchorage, Alaska $571M AUM 36.44% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
MYAM
Meiji Yasuda Asset Management Tokyo, Japan $2B AUM 22.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Natixis's CO Position: Q1 2014 in Review

Natixis sold out of Global Cord Blood Corporation (CO) in Q1 2014, closing a stake of 16,800 shares — an estimated $67K sold.

Natixis first reported a position in CO in Q4 2013 and held it in 1 quarter. The position peaked at $67K in Q4 2013. 30 funds tracked by Wall St. Rank hold CO as of Q1 2014.

  • Natixis reported no remaining Global Cord Blood Corporation position as of Q1 2014 after selling out during the quarter.
  • Natixis sold 16,800 Global Cord Blood Corporation shares in Q1 2014, an estimated $67K.
  • Natixis first reported a position in Global Cord Blood Corporation in Q4 2013 and held it in 1 quarter.
  • Natixis's Global Cord Blood Corporation position peaked at $67K in Q4 2013.
  • 30 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q1 2014.

Based on Natixis's 13F filing for Q1 2014, filed 14 May 2014.